Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS)

Erfahren Sie in diesem Video, wie Pathologen NGS-Daten für die prognostische Relevanz und die Therapiestratifizierung einsetzen.

Vorträge:
Prognostication of Chronic Lymphocytic Leukemia (CLL) using NGS
Dr. Riccardo Bomben, MD, Clinical and Experimental Onco-Hematology Unit, IRCCS CRO Aviano, Italy
Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
Wouter De Brouwer, MD, Vrije Universiteit Brussel (VUB), Universitair ziekenhuis Brussel (UZ Brussel), Department of Hematology

Invivoscribe - Produktkatalog